Abstract
Exogenous human chorionic gonadotrophin (hCG) is often used to trigger ovulation in controlled ovarian stimulation protocols. The most common hCG dose used in in vitro fertilization (IVF) cycles is 10,000 IU, although lower doses may benefit women predicted to be high responders and at risk for ovarian hyperstimulation syndrome (OHSS). The optimal hCG trigger dose that balances achieving successful IVF outcomes while minimizing the risk of OHSS has yet to be determined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
